Cellectis (CLLS) Gross Profit Growth (3y) (2018 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 411.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.16% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 4.34% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 51.16% |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 26.48% |
| Sep 30, 2023 | 49.45% |
| Jun 30, 2023 | 26.87% |
| Mar 31, 2023 | -26.08% |
| Dec 31, 2022 | 26.72% |
| Sep 30, 2022 | -26.94% |
| Jun 30, 2022 | 42.64% |
| Mar 31, 2022 | 41.69% |
| Dec 31, 2021 | -31.64% |
| Sep 30, 2021 | -195.15% |
| Jun 30, 2021 | -28.64% |
| Mar 31, 2021 | 47.31% |
| Dec 31, 2020 | -41.43% |
| Sep 30, 2020 | -31.91% |
| Jun 30, 2020 | -152.04% |
| Mar 31, 2020 | 95.10% |
| Dec 31, 2019 | -29.31% |
| Sep 30, 2019 | -27.09% |
| Jun 30, 2019 | -0.85% |
| Mar 31, 2019 | -60.35% |
| Dec 31, 2018 | -80.75% |
| Sep 30, 2018 | -83.25% |
| Jun 30, 2018 | -16.33% |
| Mar 31, 2018 | -15.46% |